Cesarean Section, Dysmenorrhea, Postoperative Adhesions
Conditions
Brief summary
The goal of this randomized controlled clinical trial is to determine whether adding abdominopelvic fascial release to a standardized stretching exercise program is more effective than stretching exercises alone in reducing menstrual pain in women following cesarean section. The study will enroll women aged 20 to 35 years with moderate to severe dysmenorrhea after cesarean delivery. Researchers will compare the effects of abdominopelvic fascial release combined with stretching exercises with stretching exercises alone on menstrual pain and scar mobility. Participants will be randomly assigned to one of two treatment groups, undergo assessments before and after the intervention period, and receive the assigned treatment according to the study protocol.
Detailed description
Cesarean section is one of the most commonly performed obstetric surgical procedures worldwide. Although it is frequently necessary to improve maternal and neonatal outcomes, postoperative healing may result in scar formation and fascial adhesions that can contribute to persistent menstrual pain, chronic pelvic pain, reduced scar mobility, abdominal tenderness, and impaired physical function. Fascial restrictions may alter tissue mobility and biomechanics, leading to pain and functional limitations. Abdominopelvic fascial release is a manual therapy technique that applies sustained, low-load pressure to restricted fascial tissues to restore tissue mobility, improve fascial gliding, reduce pain, and enhance tissue function. Previous studies have demonstrated beneficial effects of fascial release on postoperative scar mobility, pain, and functional recovery; however, evidence regarding its effectiveness in women with menstrual pain following cesarean section remains limited. The purpose of this prospective, randomized controlled trial is to evaluate whether the addition of abdominopelvic fascial release to a standardized stretching exercise program provides greater clinical benefit than a stretching exercise program alone in women with post-cesarean dysmenorrhea. Participants will be randomly assigned to one of two parallel groups and evaluated before and after completion of the intervention period using predefined clinical outcome measures. The findings of this study are expected to provide evidence regarding the effectiveness of abdominopelvic fascial release as a non-pharmacological physical therapy intervention for reducing menstrual pain and improving scar mobility following cesarean section. The results may support the integration of fascial release techniques into postpartum rehabilitation programs and contribute to evidence-based physical therapy management for women with post-cesarean pain and scar-related dysfunction.
Interventions
OTHERAbdominopelvic fascial Release
Abdominopelvic fascial release is a manual therapy intervention designed to restore mobility of the abdominal and pelvic fascial tissues by applying sustained, low-load pressure to fascial restrictions. The treatment targets the cesarean scar, abdominal fascia, diaphragm, and psoas muscle to improve fascial mobility, reduce tissue restrictions, alleviate pain, and enhance tissue function. The intervention will be administered for 30 minutes per session, twice weekly for 2 weeks by a licensed physiotherapist.
Sponsors
Cairo University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Masking description
Outcome assessments will be performed by an independent assessor who will be blinded to treatment allocation. Participants will be instructed not to disclose their assigned intervention to the assessor. Due to the nature of the interventions, participants and treating therapists cannot be blinded.
Intervention model description
Participants will be randomly assigned in a 1:1 ratio to one of two parallel groups. The control group will receive a standardized stretching exercise program, whereas the experimental group will receive myofascial release in addition to the same stretching exercise program. Outcomes will be compared between the two groups following completion of the intervention period.
Eligibility
Sex/Gender
FEMALE
Age
20 Years to 35 Years
Healthy volunteers
No
Inclusion criteria
* Females aged 20 to 35 years. * History of at least one cesarean section. * Moderate to severe primary or secondary dysmenorrhea following cesarean section. * Regular menstrual cycles (21-35 days). * Body mass index (BMI) between 18.5 and 29.9 kg/m². * At least 6 months post-cesarean section to allow complete scar healing. * Presence of restricted cesarean scar mobility on clinical examination. * Willingness to participate and provide written informed consent.
Exclusion criteria
* Pregnancy or planned pregnancy during the study period. * Previous abdominal or pelvic surgery other than cesarean section. * Endometriosis, adenomyosis, uterine fibroids requiring treatment, or other diagnosed gynecological disorders associated with pelvic pain. * Active pelvic inflammatory disease or genitourinary infection. * Neurological or musculoskeletal disorders affecting pain perception or mobility. * Systemic inflammatory, autoimmune, or connective tissue diseases. * Current participation in another physical therapy or manual therapy program targeting the abdomen or pelvis. * Use of corticosteroid injections or other invasive treatments to the abdominal or pelvic region within the previous 3 months. * Contraindications to manual therapy.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Menstrual Pain Intensity | Baseline and immediately after completion of the 4-week intervention period. | Menstrual pain intensity will be assessed using the Visual Analog Scale (VAS), a validated 10-cm scale ranging from 0 (no pain) to 10 (worst imaginable pain). The primary outcome is the change in VAS score from baseline to the end of the intervention period. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in Cesarean Scar Mobility | Baseline and immediately after completion of the 4-week intervention period. | Scar mobility will be assessed using an adheremeter. Greater mobility values indicate improved scar tissue mobility. |
| Change in Dysmenorrhea Severity | Baseline and immediately after completion of the 4-week intervention period. | Dysmenorrhea severity will be assessed using the Working ability, Location, Intensity, Days of pain, and Dysmenorrhea (WaLIDD) Score. The total score ranges from 0 to 12, with higher scores indicating more severe dysmenorrhea. |
| Change in Pressure Pain Threshold | Baseline and immediately after completion of the 4-week intervention period. | Pressure pain threshold will be assessed using a pressure algometer over the abdominal region. |
Contacts
CONTACTAmira I. Hassanein
Outcome results
None listed